Flurazepam
Product Images NDC 21695-363

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Flurazepam (NDC 21695-363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (16a5de2d 2f89 4fc2 A1cf 2d6fd11f2748 01)

Chem Structure (16a5de2d 2f89 4fc2 A1cf 2d6fd11f2748 01)
Chemical structure of flurazepam hydrochloride. The diagram shows the molecular arrangement including chlorine and fluorine atoms, bicyclic components, and two hydrochloride groups (2HCl).*
FDA Label Image

Flurazepam 30 mg (16a5de2d 2f89 4fc2 A1cf 2d6fd11f2748 02)

Flurazepam 30 mg (16a5de2d 2f89 4fc2 A1cf 2d6fd11f2748 02)
Flurazepam 30 mg capsules label by Rebel Distributors Corp. The label indicates a package of 30 capsules, with each containing 30 mg of flurazepam hydrochloride. The capsules are described as hard gelatin, printed. The label includes the product NDC 21695-363-30 and manufacturing information from West-ward Pharmaceutical Corp, Easton, NJ. Storage instructions advise controlled room temperature between 15-30°C (59-86°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.